Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8828412a08c427cf0e753b98d7339754 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-18 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6432 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-36 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
filingDate |
2019-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e1ced4d2795591ac1ef058bf8472e72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdfbc13f1871ce33c7aa37fe3d33a2bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90111f8183ea7f530d364177a9b98e5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6890aff4c6a33384f1973e0c184d13a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_829bdf40e89e36b78ec16f0f46d0b3ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f614c42788b56a79617e87d9d5cbdf9e |
publicationDate |
2021-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3817765-A1 |
titleOfInvention |
Fx activation process and its use in the preparation of a fxa composition |
abstract |
The invention relates to a high purity Coagulation Factor Xa (FXa or activated Coagulation Factor X) preparation and an activation and purification process to obtain said FXa of high purity and high degree of activation without addition of proteinaceous activators during manufacturing. |
priorityDate |
2018-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |